These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 12637924)

  • 1. Skin cancer is among the most costly of all cancers to treat for the Medicare population.
    Housman TS; Feldman SR; Williford PM; Fleischer AB; Goldman ND; Acostamadiedo JM; Chen GJ
    J Am Acad Dermatol; 2003 Mar; 48(3):425-9. PubMed ID: 12637924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of nonmelanoma skin cancer treatment in the United States.
    Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
    Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmelanoma skin cancer: an episode of care management approach.
    Housman TS; Williford PM; Feldman SR; Teuschler HV; Fleischer AB; Goldman ND; Balkrishnan R; Chen GJ
    Dermatol Surg; 2003 Jul; 29(7):700-11. PubMed ID: 12828693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and economic burden of nonmelanoma skin cancer.
    Cakir BÖ; Adamson P; Cingi C
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):419-22. PubMed ID: 23084294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare.
    Joseph AK; Mark TL; Mueller C
    Dermatol Surg; 2001 Nov; 27(11):955-9. PubMed ID: 11737130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment patterns and cost of nonmelanoma skin cancer management.
    John Chen G; Yelverton CB; Polisetty SS; Housman TS; Williford PM; Teuschler HV; Feldman SR
    Dermatol Surg; 2006 Oct; 32(10):1266-71. PubMed ID: 17034377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of nonmelanoma skin cancer screening in Crohn's disease patients.
    Okafor PN; Stallwood CG; Nguyen L; Sahni D; Wasan SK; Farraye FA; Erim DO
    Inflamm Bowel Dis; 2013 Dec; 19(13):2787-95. PubMed ID: 24193153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
    Lewis KG; Weinstock MA
    Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010.
    Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S
    J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of illness for melanoma and nonmelanoma skin cancer in Denmark.
    Bentzen J; Kjellberg J; Thorgaard C; Engholm G; Phillip A; Storm HH
    Eur J Cancer Prev; 2013 Nov; 22(6):569-76. PubMed ID: 23542376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No end in sight: the skin cancer epidemic continues.
    Donaldson MR; Coldiron BM
    Semin Cutan Med Surg; 2011 Mar; 30(1):3-5. PubMed ID: 21540015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
    Stern RS
    Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
    Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
    Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
    Yoon J; Phibbs CS; Chow A; Weinstock MA;
    J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Economic Consequences of Early Cancer After Kidney Transplantation in Contemporary Practice.
    Dharnidharka VR; Naik AS; Axelrod D; Schnitzler MA; Xiao H; Brennan DC; Segev DL; Randall H; Chen J; Kasiske B; Lentine KL
    Transplantation; 2017 Apr; 101(4):858-866. PubMed ID: 27490413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician specialty cost differences of treating nonmelanoma skin cancer.
    Chirikov VV; Stuart B; Zuckerman IH; Christy MR
    Ann Plast Surg; 2015 Jan; 74(1):93-9. PubMed ID: 24503881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for nonmelanoma skin cancer: does it have a future?
    Urosevic M; Dummer R
    Cancer; 2002 Jan; 94(2):477-85. PubMed ID: 11900233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
    Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
    Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence estimate of nonmelanoma skin cancer in the United States, 2006.
    Rogers HW; Weinstock MA; Harris AR; Hinckley MR; Feldman SR; Fleischer AB; Coldiron BM
    Arch Dermatol; 2010 Mar; 146(3):283-7. PubMed ID: 20231499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.